2-Bromo-5-fluoro-3-nitrobenzoic acid, 95.0%, 10g

4-ethyl-N-{3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl}-3-(2-{pyrazolo[1,5-a]pyrimidin-6-yl}ethynyl)benzamide, 5mg

trans,trans-4-(3,4-Difluorophenyl)-4'-vinylbicyclohexyl>98.0%(GC)1g

4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide, 95.0%, 5g

(2E)-1-(3-bromophenyl)-3-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g

2-(4-(Cyclopropylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

tert-Butyl (4-hydroxy-2-nitrophenyl)carbamate, 95.0%, 1g

2-chloro-N-[1-(4-methylphenyl)ethyl]acetamide, 95.0%, 5g

3-Ethoxy-2-fluoro-6-methyl-pyridine, 95+%, 1g

1-(tert-Butoxycarbonyl)-4-hydroxypiperidine>97.0%(GC)25g

2-Methyl-1-(piperazin-1-yl)propan-2-ol dihydrochloride, 97%, 100mg

6,7-Dihydro[1,4]dioxino[2,3-f][1,3]benzothiazol-2-amine, 95.0%, 1g

2-Bromo-4,6-dimethylpyridine, 97.0%, 1g